Ethidium Bromide Transport Across Mycobacterium Smegmatis Cell-wall: Correlation with Antibiotic Resistance

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2011 Feb 22

PMID 21332993

Citations 54

Authors

Liliana Rodrigues

Jorge Ramos

Isabel Couto

Leonard Amaral

Miguel Viveiros

Affiliations

Soon will be listed here.

Abstract

Background: Active efflux systems and reduced cell-wall permeability are considered to be the main causes of mycobacterial intrinsic resistance to many antimicrobials. In this study, we have compared the Mycobacterium smegmatis wild-type strain mc2155 with knockout mutants for porins MspA (the main porin of M. smegmatis) and MspC, the efflux pump LfrA (the main efflux pump system of M. smegmatis) and its repressor LfrR for their ability to transport ethidium bromide (EtBr) on a real-time basis. This information was then correlated with minimum inhibitory concentrations (MICs) of several antibiotics in the presence or absence of the efflux inhibitors chlorpromazine, thioridazine and verapamil.

Results: In the absence of porins MspA and MspC, accumulation of ethidium bromide decreased and the cells became more resistant to several antibiotics, whereas the knockout mutant for the LfrA pump showed increased accumulation of EtBr and increased susceptibility to EtBr, rifampicin, ethambutol and ciprofloxacin. Moreover, the efflux inhibitors caused a reduction of the MICs of streptomycin, rifampicin, amikacin, ciprofloxacin, clarithromycin and erythromycin in most of the strains tested.

Conclusions: The methodology used in this study demonstrated that porin MspA plays an important role in the influx of quaternary ammonium compounds and antibiotics and that efflux via the LfrA pump is involved in low-level resistance to several antimicrobial drugs in M. smegmatis. The results obtained with this non-pathogenic mycobacterium will be used in future studies as a model for the evaluation of the activity of the same efflux inhibitors on the susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to isoniazid and rifampicin.

Citing Articles

Systematic Determination of the Impact of Structural Edits on Accumulation into Mycobacteria.

Dash R, Liu Z, Lepori I, Chordia M, Ocius K, Holsinger K bioRxiv. 2025; .

PMID: 39868157 PMC: 11760776. DOI: 10.1101/2025.01.17.633618.

Nanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of .

Binnebose A, Mullis A, Haughney S, Narasimhan B, Bellaire B Front Antibiot. 2025; 2():1162941.

PMID: 39816663 PMC: 11732124. DOI: 10.3389/frabi.2023.1162941.

EmbB and EmbC regulate the sensitivity of to echinomycin.

He J, Gao Y, Wang J, Hameed H, Wang S, Fang C mLife. 2024; 3(3):459-470.

PMID: 39359678 PMC: 11442130. DOI: 10.1002/mlf2.12139.

Investigating the role of in intrinsic resistance to multiple drugs in .

Yusuf B, Wang S, Alam M, Zhang J, Liu Z, Lu Z Microbiol Spectr. 2024; 12(10):e0397423.

PMID: 39162545 PMC: 11448072. DOI: 10.1128/spectrum.03974-23.

Biguanide-Vancomycin Conjugates are Effective Broad-Spectrum Antibiotics against Actively Growing and Biofilm-Associated Gram-Positive and Gram-Negative ESKAPE Pathogens and Mycobacteria.

Rahn H, Liu X, Chosy M, Sun J, Cegelski L, Wender P J Am Chem Soc. 2024; 146(32):22541-22552.

PMID: 39088791 PMC: 11624893. DOI: 10.1021/jacs.4c06520.

References

Sharples D, Brown J . Correlation of the base specificity of DNA--intercalating ligands with their physico-chemical properties. FEBS Lett. 1976; 69(1):37-40. DOI: 10.1016/0014-5793(76)80648-5. View

Sander P, De Rossi E, Boddinghaus B, CANTONI R, Branzoni M, Bottger E . Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance. FEMS Microbiol Lett. 2000; 193(1):19-23. DOI: 10.1111/j.1574-6968.2000.tb09396.x. View

Li X, Zhang L, Nikaido H . Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother. 2004; 48(7):2415-23. PMC: 434187. DOI: 10.1128/AAC.48.7.2415-2423.2004. View

Ainsa J, Blokpoel M, Otal I, Young D, De Smet K, Martin C . Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol. 1998; 180(22):5836-43. PMC: 107655. DOI: 10.1128/JB.180.22.5836-5843.1998. View

Greulich K . Single molecule techniques for biomedicine and pharmacology. Curr Pharm Biotechnol. 2004; 5(3):243-59. DOI: 10.2174/1389201043376878. View

Viveiros M, Martins A, Paixao L, Rodrigues L, Martins M, Couto I . Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents. 2008; 31(5):458-62. DOI: 10.1016/j.ijantimicag.2007.12.015. View

Takiff H, Cimino M, Musso M, Weisbrod T, Martinez R, Delgado M . Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A. 1996; 93(1):362-6. PMC: 40238. DOI: 10.1073/pnas.93.1.362. View

Wolschendorf F, Mahfoud M, Niederweis M . Porins are required for uptake of phosphates by Mycobacterium smegmatis. J Bacteriol. 2007; 189(6):2435-42. PMC: 1899398. DOI: 10.1128/JB.01600-06. View

De Rossi E, Ainsa J, Riccardi G . Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev. 2006; 30(1):36-52. DOI: 10.1111/j.1574-6976.2005.00002.x. View

10.

DUBNAU E, Chan J, Raynaud C, Mohan V, Laneelle M, Yu K . Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol. 2000; 36(3):630-7. DOI: 10.1046/j.1365-2958.2000.01882.x. View

11.

Stephan J, Bender J, Wolschendorf F, Hoffmann C, Roth E, Mailander C . The growth rate of Mycobacterium smegmatis depends on sufficient porin-mediated influx of nutrients. Mol Microbiol. 2005; 58(3):714-30. DOI: 10.1111/j.1365-2958.2005.04878.x. View

12.

Niederweis M . Mycobacterial porins--new channel proteins in unique outer membranes. Mol Microbiol. 2003; 49(5):1167-77. DOI: 10.1046/j.1365-2958.2003.03662.x. View

13.

Martins M, Santos B, Martins A, Viveiros M, Couto I, Cruz A . An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo. 2006; 20(5):657-64. View

14.

Sander P, Meier A, Bottger E . rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol. 1995; 16(5):991-1000. DOI: 10.1111/j.1365-2958.1995.tb02324.x. View

15.

Brennan P, Nikaido H . The envelope of mycobacteria. Annu Rev Biochem. 1995; 64:29-63. DOI: 10.1146/annurev.bi.64.070195.000333. View

16.

Schumacher A, Trittler R, Bohnert J, Kummerer K, Pages J, Kern W . Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother. 2006; 59(6):1261-4. DOI: 10.1093/jac/dkl380. View

17.

Stephan J, Mailaender C, Etienne G, Daffe M, Niederweis M . Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis. Antimicrob Agents Chemother. 2004; 48(11):4163-70. PMC: 525411. DOI: 10.1128/AAC.48.11.4163-4170.2004. View

18.

Rodrigues L, Wagner D, Viveiros M, Sampaio D, Couto I, Vavra M . Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J Antimicrob Chemother. 2008; 61(5):1076-82. DOI: 10.1093/jac/dkn070. View

19.

Niederweis M, Ehrt S, Heinz C, Klocker U, Karosi S, Swiderek K . Cloning of the mspA gene encoding a porin from Mycobacterium smegmatis. Mol Microbiol. 1999; 33(5):933-45. DOI: 10.1046/j.1365-2958.1999.01472.x. View

20.

Ramon-Garcia S, Martin C, Thompson C, Ainsa J . Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother. 2009; 53(9):3675-82. PMC: 2737831. DOI: 10.1128/AAC.00550-09. View